A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype

Clinical trial NCT05522439 · COMPLETED

Trial details

NCT number: NCT05522439
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma With Eosinophilic Phenotype

Start date: 2022-12-22
Primary completion: 2024-09-12
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.